Ultomiris (ravulizumab)

pCPA File Number: 21780

Negotiation Status:

Concluded with an LOI

Indication(s):

Paroxysmal nocturnal hemoglobinuria (PNH)

Sponsor/Manufacturer:

Alexion Pharma Canada Corp.

CADTH Project Number:

SR0700

pCPA Engagement Letter Issued:

2023-05-18

Negotiation Process Concluded:

2023-10-12